PMID- 17953712 OWN - NLM STAT- MEDLINE DCOM- 20080215 LR - 20220331 IS - 1349-7006 (Electronic) IS - 1347-9032 (Linking) VI - 99 IP - 1 DP - 2008 Jan TI - Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer. PG - 121-8 AB - Hypoxia induced drug resistance is a major obstacle in the development of effective cancer therapy. Our previous study revealed that hypoxia-inducible factor-1 (HIF-1), the major transcriptional factor significantly activated by hypoxia, was overexpressed in gastric vincristine-resistant cells SGC7901/vincristine (VCR) under normoxic conditions, which suggested that it was associated with drug resistance in gastric cancer cells. In the present study, a colony-forming assay revealed that hypoxia and forced HIF-1 alpha expression increased maximal -8.9-fold or -14.8-fold of IC(50) toward vincristine in gastric cancer cell lines SGC7901 and SGC7901/VCR, respectively (P < 0.01). Annexin-V/propidium iodide staining analysis revealed hypoxia or forced HIF-1 alpha expression reduced apoptosis by 24% or 18% in SGC7901 cells (P < 0.05). Flow cytometry analysis of intracellular adriamycin revealed that hypoxia and forced expression of HIF-1 alpha increased -1.79-fold or -2.36-fold of the adriamycin releasing index, respectively (P < 0.05). However, resistance acquisition subject to hypoxia in vitro and in vivo was suppressed by blocking HIF-1 alpha expression with siRNA. We further demonstrated that HIF-1 alpha overexpression showed a 1.85-fold increased expression of Bcl-2 and a 2.16-fold decreased expression of Bax, and also showed significantly induced expression of p-gp and MRP1, which indicated that HIF-1 alpha may confer hypoxia-induced drug resistance via inhibition of drug-induced apoptosis and decreases in intracellular drug accumulation. FAU - Liu, Lili AU - Liu L AD - State Key Laboratory of Cancer Biology, Institute of Digestive Diseases, Xijing Hospital, Fourth Military Medical University, 15 Changle West Road, Xi'an 710032, China. FAU - Ning, Xiaoxuan AU - Ning X FAU - Sun, Li AU - Sun L FAU - Zhang, Hongbo AU - Zhang H FAU - Shi, Yongquan AU - Shi Y FAU - Guo, Changcun AU - Guo C FAU - Han, Shuang AU - Han S FAU - Liu, Jie AU - Liu J FAU - Sun, Shiren AU - Sun S FAU - Han, Zheyi AU - Han Z FAU - Wu, Kaichun AU - Wu K FAU - Fan, Daiming AU - Fan D LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20071022 PL - England TA - Cancer Sci JT - Cancer science JID - 101168776 RN - 0 (ATP Binding Cassette Transporter, Subfamily B, Member 1) RN - 0 (BAX protein, human) RN - 0 (HIF1A protein, human) RN - 0 (Hypoxia-Inducible Factor 1, alpha Subunit) RN - 0 (Multidrug Resistance-Associated Proteins) RN - 0 (Proto-Oncogene Proteins c-bcl-2) RN - 0 (RNA, Small Interfering) RN - 0 (bcl-2-Associated X Protein) RN - 5J49Q6B70F (Vincristine) RN - Y49M64GZ4Q (multidrug resistance-associated protein 1) SB - IM MH - ATP Binding Cassette Transporter, Subfamily B, Member 1/biosynthesis/genetics/metabolism MH - Apoptosis/drug effects MH - Cell Hypoxia/physiology MH - Cell Line, Tumor MH - Drug Resistance, Neoplasm MH - Humans MH - Hypoxia-Inducible Factor 1, alpha Subunit/biosynthesis/genetics/*metabolism MH - Multidrug Resistance-Associated Proteins/biosynthesis/genetics MH - Proto-Oncogene Proteins c-bcl-2/biosynthesis MH - RNA, Small Interfering/genetics MH - Stomach Neoplasms/*drug therapy/genetics/*metabolism/pathology MH - Transfection MH - Vincristine/*pharmacology MH - bcl-2-Associated X Protein/antagonists & inhibitors EDAT- 2007/10/24 09:00 MHDA- 2008/02/19 09:00 CRDT- 2007/10/24 09:00 PHST- 2007/10/24 09:00 [pubmed] PHST- 2008/02/19 09:00 [medline] PHST- 2007/10/24 09:00 [entrez] AID - CAS643 [pii] AID - 10.1111/j.1349-7006.2007.00643.x [doi] PST - ppublish SO - Cancer Sci. 2008 Jan;99(1):121-8. doi: 10.1111/j.1349-7006.2007.00643.x. Epub 2007 Oct 22.